| 产品详情 |
| Edit |   |
|---|
| Product Name | SW 780 |
|---|
| Description | The SW 780 line was established in 1974 by A. Leibovitz from a grade I transitional cell carcinoma. The patient had preoperative chemotherapy (Thiotepa). The cells have a reported plating efficiency of 41%. |
|---|
| Size | 1 vial |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | ABC-TC1190 |
|---|
| Price | |
|---|
| Order / More Info | SW 780 from ACCEGEN BIOTECH |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|